Sanofi Advances Legal Battles Over mRNA Patent Rights Against Pfizer and Moderna
Sanofi has launched fresh patent litigation actions against Pfizer and Moderna, focusing on mRNA technology used in COVID-19 vaccines. These legal moves represent new chapters in the complex patent disputes surrounding the development and commercialization of mRNA vaccines, underscoring the competitive and high-stakes…